LOXL2 and pulmonary fibrosis: Moreover, inhibition of LOXL2 activity by a monoclonal antibody resulted in a significant drop in cross-linked collagen, alongside suppression of TGFβ signalling, fibroblast activation and production of growth factors and cytokines in the bleomycin model of lung fibrosis [52].